The South Dakota Department of Health has reported the first two deaths related to influenza in the 2025-2026 flu season. Read More »

Mark Cuban emphasizes breaking up vertically integrated insurers for true healthcare price relief. Read More »

Empower Pharmacy is relocating its operations from New Jersey to Houston following a lawsuit by Eli Lilly over compounded tirzepatide. Read More »

PCCA has announced a partnership with Pillumina, a company focused on sustainable pharmacy packaging, to introduce aluminum pill bottles for compounding pharmacies. Read More »

The North Carolina Department of Health and Human Services has reported a confirmed measles case involving a traveler who passed through Raleigh-Durham International Airport's Terminal 2 on December 10. Read More »

The federal 340B program is projected to grow significantly next year due to increased participation rather than rising drug prices. Read More »

People who were at Rapid City Regional Airport on December 10, 2025, between 10:45 a.m. and 12:45 p.m. Mountain Time may have been exposed to measles, according to a notice from the South Dakota Department of Health. Read More »

Pharmacy benefit managers face scrutiny as calls grow for increased oversight due to widespread U.S. pharmacy closures affecting millions living in "pharmacy deserts." Read More »

The article discusses concerns raised by Dutch Rojas about the dominance of a few insurers and PBMs in U.S. healthcare markets. Read More »

The Senate HELP Committee recently held a hearing to address concerns over the growth of the U.S.'s largest drug-purchasing channel under the 340B program. Read More »

PCCA has announced that SuspendIt, one of its proprietary compounding bases, has received verification from the U.S. Pharmacopeia (USP). Read More »

The FDA has warned about counterfeit Ozempic entering the U.S. drug supply chain with non-authentic lot numbers. Read More »

The National Community Pharmacists Association (NCPA) has expressed its support for the reintroduction of the Pharmacists Fight Back Act, a bill aimed at reforming pharmacy benefit manager (PBM) practices. Read More »

Anthony M. DiGiorgio, DO, MHA, an assistant professor of neurosurgery at the University of California, San Francisco (UCSF), expressed concerns about the 340B program during an appearance on the Healthcare Unfiltered podcast. Read More »

The North Carolina Department of Health and Human Services (NC DHHS) has revised its regulations concerning the return and disposal of controlled substances from long-term care facilities. Read More »

Legislation aimed at increasing oversight of pharmacy benefit managers (PBMs) was introduced in the U.S. Senate, with support from both parties. Read More »

The National Community Pharmacists Association (NCPA) has announced a series of upcoming events aimed at supporting pharmacists and pharmacy teams throughout December and into early 2026. Read More »

Heath Veuleman, a Healthcare Strategist for Seersucker Strategies, has expressed concerns about various hospital cost centers, including 340B profits, facility fees, provider taxes, and higher site-based Medicare payments. Read More »

DC Health has released its 2025 Perinatal Health and Infant Mortality Report, which covers data from 2019 to 2023 and details trends in maternal and infant health in Washington, DC. Read More »

Molly Jenkins, Senior Director of Public Affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA), said that the 340B program is increasing Medicare costs by blocking rebates and worsening taxpayer burdens. Read More »